Thursday, November 23, 2017

Oneinforty.org - our own TTT sister, Debra, tells her story

This piece was written and presented by our own TTT sister, Debra:
My name is Debra and I am that one in forty Ashkenazi Jew that has a BRCA gene mutation. I think my story is compelling evidence for every Ashkenazi Jew to get tested for the BRCA gene mutations. If it hadn’t been for the BRCA test, I wouldn’t be here today.
Here's my story.

Monday, November 20, 2017

New Blood Test Developed to Diagnose OC

A shout out to Betsy for sending me this link! Dana Farber has developed a new blood test that so far, has had almost 100% accuracy rate in detecting ovarian cancer at an earlier stage - much more accurate that ultra-sound (fewer than 5% of abnormal u/s tests are positive for OC compared w/almost 100% of abnormal test results positive for OC).

Now, these researchers are going to see how tracking these microRNAs change as risk increases.

Here's the link to read about this research and I'm also going to attempt to cut and paste the article here.

New Blood Test Developed to Diagnose Ovarian Cancer

  • Non-invasive diagnostic tool being developed to measure circulating microRNAs to predict ovarian cancer with specificity

Thursday, November 16, 2017

The Next Generation: Ovarian Cancer Research Webinar

Hi folks,
Well it's been a while since I posted but I have added some posts to our FB public and private pages.

I want to thank Anne for alerting me to this webinar sponsored by the Ovarian Cancer Research Fund Alliance.

Registration is required so be sure to do that but it looks like it's going to be an exciting event. These researchers will be discussing the direction of ovarian cancer research. Michael Goldberg, PhD from Dana Farber will be talking as well as Ron Chandler, PhD (from Michigan State University) and Hui Shen, PhD (from Van Andel Research Institute.

Here's the information but be sure to follow this link to register (it's free):

Webinar: The Next Generation: Ovarian Cancer Research from OCRFA’s Liz Tilberis Grantees

November 20 @ 6:00 pm - 7:00 pm EST 

OCRFA funds millions of dollars in innovative ovarian cancer research every year. Many of these grants help solidify the careers of young ovarian cancer researchers, ensuring the next generation of scientists can continue making progress toward a cure.
Join us on Monday, November 20th to hear from three of our recent grantees on how their basic ovarian cancer research projects are essential to the fight against the disease.